# A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

> **NCT01651663** · PHASE4 · UNKNOWN · sponsor: **Pharmstandard** · enrollment: 840 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Arbidol (Umifenovir)
- **OTHER:** placebo
- **DRUG:** Arbidol (Umifenovir)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01651663
- **Lead sponsor:** Pharmstandard
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2013-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651663, "A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01651663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*